Keros Therapeutics, Inc. (KROS)
10.50
-0.49
(-4.46%)
USD |
NASDAQ |
May 15, 16:00
10.51
+0.01
(+0.10%)
After-Hours: 20:00
Keros Therapeutics Total Assets (Quarterly) : 312.29M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.179B |
| PTC Therapeutics, Inc. | 2.869B |
| Insmed, Inc. | 2.076B |
| United Therapeutics Corp. | 6.714B |
| Enanta Pharmaceuticals, Inc. | 314.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.66M |
| Shareholders Equity (Quarterly) | 285.63M |
| Debt to Equity Ratio | 0.0571 |
| Current Ratio | 22.62 |
| Net Debt Paydown Yield | 0.23% |